Amiodarone

Amiodarone

March 24, 2021

An audit has identified that in Northamptonshire there are some patients on long term amiodarone who are not under cardiology follow up.

 

The NICE Clinical Guideline on Atrial Fibrillation: Management (CG180) states that amiodarone should not be used long term for rate control in atrial fibrillation (AF) and that where used for rhythm control before or after electrical cardioversion it should only be for up to 12 months.

If it is prescribed long term patients should remain under cardiology supervision. This is due to the potential toxicity of amiodarone in long term use.

 

A Tablet Press Extra with guidance for referring these patients for cardiology follow up has been agreed with the cardiology departments at KGH and NGH.

 

As this is a significant patient safety issue these patients should be referred as soon as possible.

However the referrals will be triaged and it may be some months before all patients have been offered appointments.

It is likely that most of these reviews will be conducted virtually.

Tablet Press Extra Amiodarone March 2021




More Latest News >

Delaying our LPC elections

Delaying LPC electionsThe term of office for LPC members expires on 31st March 2022 and for the LPC to continue, elections...

Gluten Free consultation process

In October NHSE&I  confirmed extension of the Gluten Free Food Service in Northamptonshire until 31st March 2021.  We would like...

Ramadan

Ramadan – coronavirus resources for pharmacy teams

Amiodarone

An audit has identified that in Northamptonshire there are some patients on long term amiodarone who are not under cardiology...

Giles Owen, Northamptonshire CCG Deputy Director and Head of Prescribing & Medicines Management has previously highlighted in Tablet Press that 4...

Maternity Services MK

Dr. Sanhita Chakrabarti  Clinical Lead Bedfordshire Clinical Commissioning Group requests that pharmacy colleagues in Milton Keynes advise expectant mothers to...

Updated Covid-19 SOP

Community Pharmacy in the context of Coronavirus (Covid-19) SOP has been updated (26.10.20). The changes are highlighted in yellow. C0796-covid-19-community-pharmacy-sop-v4

PQS 2020/21 Part 2 Infection Control/ AMS

https://psnc.org.uk/services-commissioning/pharmacy-quality-scheme/pqs-2020-21-part-2/ We have had a number of contractor queries highlighting difficulty identifying local antibiotic formularies in relation to the PQS...

PQS 2020/21

PQS announced for first part of 2020/21 July 13, 2020 A new Pharmacy Quality Scheme (PQS) for the first part...